Decellularized bone marrow extracellular matrix
US7326571B2 · kind B2 · utility
29Cited by
32References
19Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 17, 2003 |
| Grant date | Feb 5, 2008 |
| Priority date | — |
| Expiry date | Jun 2, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is directed to compositions comprising decellularized bone marrow extracellular matrix and uses thereof. Methods for repairing or regenerating defective, diseased, damaged or ischemic tissues or organs in a subject, preferably a human, using the decellularized bone marrow extracellular matrix of the invention are also provided. The invention is further directed to a medical device, preferably a stent or an artificial heart, and biocompatible materials, preferably a tissue regeneration scaffold, comprising decellularized bone marrow extracellular matrix for implantation into a subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.